185 related articles for article (PubMed ID: 38188362)
1. Identification of prognostic risk score of disulfidptosis-related genes and molecular subtypes in glioma.
Jiang Q; Ling GY; Yan J; Tan JY; Nong RB; Li JW; Deng T; Mo LG; Huang QR
Biochem Biophys Rep; 2024 Mar; 37():101605. PubMed ID: 38188362
[TBL] [Abstract][Full Text] [Related]
2. Molecular map of disulfidptosis-related genes in lung adenocarcinoma: the perspective toward immune microenvironment and prognosis.
Zhao F; Su L; Wang X; Luan J; Zhang X; Li Y; Li S; Hu L
Clin Epigenetics; 2024 Feb; 16(1):26. PubMed ID: 38342890
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics-based analysis of the relationship between disulfidptosis and prognosis and treatment response in pancreatic cancer.
Xiong Y; Kong X; Mei H; Wang J; Zhou S
Sci Rep; 2023 Dec; 13(1):22218. PubMed ID: 38097783
[TBL] [Abstract][Full Text] [Related]
4. Signature Construction and Disulfidptosis-Related Molecular Cluster Identification for Better Prediction of Prognosis in Glioma.
Zhuang Y; Chen J; Mai Z; Huang W; Zhong W
J Mol Neurosci; 2024 Apr; 74(2):38. PubMed ID: 38573391
[TBL] [Abstract][Full Text] [Related]
5. Identification of disulfidptosis related subtypes, characterization of tumor microenvironment infiltration, and development of DRG prognostic prediction model in RCC, in which
Xu K; Zhang Y; Yan Z; Wang Y; Li Y; Qiu Q; Du Y; Chen Z; Liu X
Front Immunol; 2023; 14():1205250. PubMed ID: 37426643
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk of disulfidptosis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in bladder cancer based on a machine learning survival framework.
Zhao S; Wang L; Ding W; Ye B; Cheng C; Shao J; Liu J; Zhou H
Front Endocrinol (Lausanne); 2023; 14():1180404. PubMed ID: 37152941
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a disulfidptosis-related scoring system to predict clinical outcome and immunotherapy response in acute myeloid leukemia by integrated analysis of single-cell and bulk RNA-sequencing.
Zhong F; Jiang J; Yao FY; Liu J; Shuai X; Wang XL; Huang B; Wang X
Front Pharmacol; 2023; 14():1272701. PubMed ID: 38053840
[No Abstract] [Full Text] [Related]
8. Disulfidptosis-related signature predicts prognosis and characterizes the immune microenvironment in hepatocellular carcinoma.
Tang J; Peng X; Xiao D; Liu S; Tao Y; Shu L
Cancer Cell Int; 2024 Jan; 24(1):19. PubMed ID: 38195525
[TBL] [Abstract][Full Text] [Related]
9. Pancancer analysis reveals the role of disulfidptosis in predicting prognosis, immune infiltration and immunotherapy response in tumors.
Huang J; Xu Z; Chen D; Zhou C; Shen Y
Medicine (Baltimore); 2023 Dec; 102(52):e36830. PubMed ID: 38206694
[TBL] [Abstract][Full Text] [Related]
10. Machine learning identification and immune infiltration of disulfidptosis-related Alzheimer's disease molecular subtypes.
Zhu Y; Kong L; Han T; Yan Q; Liu J
Immun Inflamm Dis; 2023 Oct; 11(10):e1037. PubMed ID: 37904698
[TBL] [Abstract][Full Text] [Related]
11. Correlation analysis of disulfidptosis-related gene signatures with clinical prognosis and immunotherapy response in sarcoma.
Xu J; Guo K; Sheng X; Huang Y; Wang X; Dong J; Qin H; Wang C
Sci Rep; 2024 Mar; 14(1):7158. PubMed ID: 38531930
[TBL] [Abstract][Full Text] [Related]
12. Identification of disulfidptosis-related subtypes and development of a prognosis model based on stacking framework in renal clear cell carcinoma.
Peng K; Wang N; Liu Q; Wang L; Duan X; Xie G; Li J; Ding D
J Cancer Res Clin Oncol; 2023 Nov; 149(15):13793-13810. PubMed ID: 37530800
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of a novel molecular classification based on disulfidptosis-related genes to predict prognosis and immunotherapy efficacy in hepatocellular carcinoma.
Yang L; Zhang W; Yan Y
Aging (Albany NY); 2023 Jul; 15(13):6135-6151. PubMed ID: 37399661
[TBL] [Abstract][Full Text] [Related]
14. A novel disulfidptosis-associated expression pattern in breast cancer based on machine learning.
Wang Z; Du X; Lian W; Chen J; Hong C; Li L; Chen D
Front Genet; 2023; 14():1193944. PubMed ID: 37456667
[No Abstract] [Full Text] [Related]
15. Integrative landscape analysis of prognostic model biomarkers and immunogenomics of disulfidptosis-related genes in breast cancer based on LASSO and WGCNA analyses.
Liu S; Zheng Y; Li S; Du Y; Liu X; Tang H; Meng X; Zheng Q
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16851-16867. PubMed ID: 37736788
[TBL] [Abstract][Full Text] [Related]
16. Leveraging a disulfidptosis-based signature to improve the survival and drug sensitivity of bladder cancer patients.
Chen H; Yang W; Li Y; Ma L; Ji Z
Front Immunol; 2023; 14():1198878. PubMed ID: 37325625
[TBL] [Abstract][Full Text] [Related]
17. Machine learning- and WGCNA-mediated double analysis based on genes associated with disulfidptosis, cuproptosis and ferroptosis for the construction and validation of the prognostic model for breast cancer.
Xu L; Wang S; Zhang D; Wu Y; Shan J; Zhu H; Wang C; Wang Q
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16511-16523. PubMed ID: 37712959
[TBL] [Abstract][Full Text] [Related]
18. The disulfidptosis-related signature predicts prognosis and immune features in glioma patients.
Wang X; Yang J; Yang F; Mu K
Sci Rep; 2023 Oct; 13(1):17988. PubMed ID: 37864127
[TBL] [Abstract][Full Text] [Related]
19. Disulfidptosis classification of hepatocellular carcinoma reveals correlation with clinical prognosis and immune profile.
Wang T; Guo K; Zhang D; Wang H; Yin J; Cui H; Wu W
Int Immunopharmacol; 2023 Jul; 120():110368. PubMed ID: 37247499
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of disulfidptosis-related genes: a prognosis model construction and tumor microenvironment characterization in clear cell renal cell carcinoma.
Yi B; Wei X; Liu D; Jing L; Xu S; Zhang M; Liang Z; Liu R; Zhang Z
Aging (Albany NY); 2024 Feb; 16(4):3647-3673. PubMed ID: 38358909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]